The Cancer Survival section is dedicated to the investigation, analysis, and interpretation of all aspects of cancer survival, with a commitment to sharing new knowledge that contributes to improving outcomes for patients with cancer worldwide. The section brings together research with a wide array of study designs and methodological approaches, including both traditional and innovative techniques, to maximize the breadth and depth of knowledge.

This section will focus primarily on:

• Epidemiological examinations of cancer survival: studies of the influence of age, sex, race, geographical location, and socioeconomic factors on cancer outcomes, and the impact of stage at diagnosis, histological or molecular type, and the effect of treatment regimens. We will also consider submissions that focus on the impact on cancer survival of health system or economic factors that influence access to or discontinuation of treatment, or the quality of treatment.

• Statistical modeling and analysis: studies that employ robust statistical models, innovative data analytics, computational approaches, or machine learning algorithms to understand and predict factors that may influence the probability of cancer survival, and to inform personalized cancer care.

• Approaches to cancer survival: studies of either conventional or emerging treatment strategies and their impact on survival, as well as factors that may influence physician and patient decisions about treatment.

• Interdisciplinary collaborations: submissions that may involve researchers from several scientific and clinical disciplines, including oncology, epidemiology, biostatistics, bioinformatics, public health, healthcare planning, and related disciplines, to create a comprehensive perspective of cancer survival.

• Reviews: reviews of any of the aspects of cancer survival listed above.

The Cancer Survival section of the journal is intended to be broad, but some areas are outside of its scope. We would not accept the following types of article:

• Basic laboratory research: basic laboratory research is a cornerstone of scientific understanding, but this section focuses on survival, epidemiology, statistics, and clinical outcomes, rather than primary cellular or molecular biology research.

• Early-stage drug development: preclinical studies, early-stage drug discovery and design, or reports on the synthesis and characterization of compounds with therapeutic potential.

• Cancer survivorship: investigations of the physical, psychological, and social issues faced by cancer survivors, and of approaches to improve their quality of life. Such studies should be submitted to the Cancer Rehabilitation section of this journal.

• Case reports: individual case reports fall outside the scope of this section.

• Studies without survival outcomes: studies that do not have a direct impact or a clear linkage to cancer survival will generally fall outside the scope of this section.

This section will present high-quality research that informs our understanding of cancer survival on a broad scale, highlighting advances in study design, methodology, statistics, epidemiology, clinical outcomes, and public health, and promoting research that may have a significant impact on our understanding of patterns, trends, and inequalities in cancer survival, with the underlying goal of improving the survival of all cancer patients.

Cancer Survival in Children